Neoleukin Therapeutics Inc (NLTX): Neo-2/15 is very small and very stable....

S&P 500

US TECH 100

Dow Jones

Brent Oil

Bitcoin

Neoleukin Therapeutics Inc (NLTX)

Reply Private New

Keep Last Read

Next 10 Prev Next

Schrogtergracht

Send PM Follow Ignore

Followers	0
Posts	61
Boards Moderated	0
Alias Born	12/10/2020

Schrogtergracht

Re: None

Wednesday, 12/23/2020 6:27:21 PM

Wednesday, December 23, 2020 6:27:21 PM

Neo-2/15 is very small and very stable. Because we designed it from scratch, we understand all its parts, and we can continue to improve it making it even more stable and active,” Silva Manzano added.

https://www.oncozine.com/neoleukin-2-15-neo-2-15-a-novel-immunotherapy-agent-designed-to-avoiding-common-side-effects/

The "from scratch"... Through 'less is more' to an optimal design.
Employ A.I., quantum computing and the moment you can map and describe the one it automatically produces the other.

Instant medicines; unique and infinite

Piece of cake. Now where's the monies?

Keep Last Read

Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

1D
1M
3M
6M
1Y
5Y

Detailed Quote

Recent NLTX News

Form 8-K - Current report • Edgar (US Regulatory) • 05/07/2024 10:20:01 AM
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 04/26/2024 06:34:31 PM
Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 04/26/2024 06:33:59 PM
Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 04/26/2024 06:33:12 PM
Form 8-K - Current report • Edgar (US Regulatory) • 04/22/2024 08:44:21 PM
Form 8-K - Current report • Edgar (US Regulatory) • 04/02/2024 07:43:33 PM
Form 8-K - Current report • Edgar (US Regulatory) • 03/18/2024 08:10:58 PM
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/18/2024 08:04:38 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/15/2024 12:54:55 AM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/15/2024 12:53:21 AM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/15/2024 12:51:43 AM
Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/07/2024 09:29:25 PM
Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/04/2024 11:20:58 PM
Form 8-K - Current report • Edgar (US Regulatory) • 03/04/2024 12:30:39 PM
Form 8-K - Current report • Edgar (US Regulatory) • 02/21/2024 09:07:08 PM
Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 02/20/2024 09:16:50 PM
Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 02/14/2024 11:05:00 PM
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/14/2024 09:26:22 PM
Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 02/14/2024 09:16:35 PM
Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 02/14/2024 08:08:52 PM
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/14/2024 02:19:20 PM
Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/06/2024 09:18:30 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/19/2024 12:01:01 AM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/18/2024 11:58:27 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/18/2024 11:56:12 PM

More NLTX News

InvestorsHub NewsWire

FEATURED Cannabix Technologies Launches New Compact Breath Logix Workplace Series and Prepares for Delivery to South Africa • May 7, 2024 8:51 AM

Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM

NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM

ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM

Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM

Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM

Start posting your company's news

Only $200 per official company press release!

InvestorsHub community

Register for free to join our community of investors and share your ideas

You'll also get access to streaming quotes, interactive charts, trades, portfolio, live options flow